Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C39H48N4O5 |
| Molecular Weight | 652.8222 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)NC(=O)[C@@H]1CN(CC2=CC3=C(O2)C=CC=C3)CCN1C[C@@H](O)C[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H]5[C@H](O)CC6=C5C=CC=C6
InChI
InChIKey=AOMZDQMIOCTPQP-QHQMVRJISA-N
InChI=1S/C39H48N4O5/c1-39(2,3)41-38(47)33-25-42(24-31-21-28-14-8-10-16-35(28)48-31)17-18-43(33)23-30(44)20-29(19-26-11-5-4-6-12-26)37(46)40-36-32-15-9-7-13-27(32)22-34(36)45/h4-16,21,29-30,33-34,36,44-45H,17-20,22-25H2,1-3H3,(H,40,46)(H,41,47)/t29-,30+,33+,34-,36+/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Determination of L-756 423, a novel HIV protease inhibitor, in human plasma and urine using high-performance liquid chromatography with fluorescence detection. | 1999 Sep 24 |
|
| Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors. | 2000 Sep 7 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5481481
Created by
admin on Sat Dec 16 08:18:28 UTC 2023 , Edited by admin on Sat Dec 16 08:18:28 UTC 2023
|
PRIMARY | |||
|
216863-66-0
Created by
admin on Sat Dec 16 08:18:28 UTC 2023 , Edited by admin on Sat Dec 16 08:18:28 UTC 2023
|
PRIMARY | |||
|
DB02009
Created by
admin on Sat Dec 16 08:18:28 UTC 2023 , Edited by admin on Sat Dec 16 08:18:28 UTC 2023
|
PRIMARY | |||
|
862SGU1BRL
Created by
admin on Sat Dec 16 08:18:28 UTC 2023 , Edited by admin on Sat Dec 16 08:18:28 UTC 2023
|
PRIMARY |
SUBSTANCE RECORD
